Document is current

Article History

Received: 14 May 2018

Accepted: 27 February 2019

First Online: 15 March 2019

Ethics approval and consent to participate

: The protocol (version 3, dated 7 December 2017) was approved by the ethical committee (CMO Arnhem-Nijmegen) and the board of directors of the Radboudumc (registration number 2017–3711). The study is registered at the Netherlands Trial Register (NTR6880). The trial will be conducted in agreement with the principles of the Declaration of Helsinki. All participants will be informed about the purpose of the trial, the risks, and the potential benefits. Written informed consent will be obtained by the local study coordinator from each participant. For those patients who are not mentally capable of signing informed consent in the acute setting, oral assent will be obtained. This will allow us to start the intervention while giving us an opportunity to obtain informed consent at a later stage when the patients are stable enough. Informed consent will be obtained prior to the measurements.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.